Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,334,142
in 2 filings, $1.3M under 10b5-1 plans

Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Fordyce Marshall −$1.3M PRESIDENT AND CEO sold 14% of stake
Date Insider Transaction Shares Price Value Owned after
2022-06-15 Grant Sean Chief Financial Officer Purchase +857 $13.60 $12K 857
2022-06-15 Grant Sean Chief Financial Officer Purchase +992 $13.60 $13K 992
2022-05-31 Curley Joanne Chief Development Officer Option exercise +400 $6.37 $3K 25,594
2022-05-31 Curley Joanne Chief Development Officer Sale −400 $15.22 $6K 25,194
2022-05-31 Curley Joanne Chief Development Officer Option exercise · Stock Option (right to buy) −400 25,491
2022-05-24 Hall Kimball Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 Cheng Andrew Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 ENRIGHT PATRICK G Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 Katabi Maha Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 Morrison Scott W Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 SEIDENBERG BETH C Director Grant or award · Stock Option (right to buy) +9,925 9,925
2022-05-24 MORRISSEY MICHAEL Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-02-16 Curley Joanne Chief Development Officer Grant or award · Stock Option (right to buy) +52,964 52,964
2022-02-16 Lin Celia Chief Medical Officer Grant or award · Stock Option (right to buy) +52,412 52,412
2022-02-16 Young Joseph R SVP, Finance, Chief Acct Offcr Grant or award · Stock Option (right to buy) +36,729 36,729
2022-02-16 Grant Sean Chief Financial Officer Grant or award · Stock Option (right to buy) +90,000 90,000
2022-02-16 Fordyce Marshall President and CEO Grant or award · Stock Option (right to buy) +176,154 176,154
2022-02-10 Longitude Capital Partners IV, LLC 10% owner Purchase +333,333 $15.00 $5.0M 3,429,927
2022-02-10 ENRIGHT PATRICK G Director Purchase +333,333 $15.00 $5.0M 3,429,927
2022-02-10 Sofinnova Venture Partners X, L.P. 10% owner Purchase +266,666 $15.00 $4.0M 3,181,442

Page 27 of 30 · 581 trades